Estimating the potential population impact of stepwise screening strategies for identifying and treating individuals at high risk of Type 2 diabetes: a modelling study

作者: P. Chamnan , R. K. Simmons , K. T. Khaw , N. J. Wareham , S. J. Griffin

DOI: 10.1111/J.1464-5491.2012.03609.X

关键词:

摘要: Diabet. Med. 29, 893–904 (2012) Abstract Background  Diabetes risk assessment has been proposed as part of the National Health Service Checks programme, and HbA1c recently recommended a diagnostic test for diabetes at threshold 48 mmol/mol (6.5%). We estimated potential population impact different stepwise screening strategies to identify individuals high who might be offered preventive interventions. Methods  Using data from 5910 participants in European Prospective Investigation Cancer (EPIC)-Norfolk cohort with measurements, we modelled identifying treating Type 2 using cut-off points without stage prestratification. For each strategy, number needed have test, treat prevent one new case diabetes, cases that could prevented over 3 years. Relative reductions effects intensive lifestyle intervention were derived US Prevention Program. Results  Compared inviting all an average primary care trust approach simple routine such age anthropometric indices slightly lower (lower-upper estimates) 3 years (224 [130–359] 193 [109–315] respectively) but would only require half invited blood test. A total 162 (88–274) by Cambridge score ≥ 0.15, 40% requiring tests. participant completed questionnaire (FINDRISC) was less effective, mainly relating response rate. Providing interventions those 37–< 48 mmol/mol (5.5–< 6.5%) more disproportionately higher workload, compared 42–< 48 mmol/mol (6.0–< 6.5%). Conclusions  mass screening, stratification followed (6.0–< 6.5%) suitable fewer cost-savings.

参考文章(44)
Luben R, Welch A, Day N, Oakes S, Khaw Kt, Bingham S, Wareham N, EPIC-Norfolk: study design and characteristics of the cohort. European Prospective Investigation of Cancer. British Journal of Cancer. pp. 95- 103 ,(1999)
D. Preiss, K. Khunti, N. Sattar, Combined cardiovascular and diabetes risk assessment in primary care Diabetic Medicine. ,vol. 28, pp. 19- 22 ,(2011) , 10.1111/J.1464-5491.2010.03157.X
James Maxwell Glover Wilson, Gunnar Jungner, World Health Organization, None, Principles and practice of screening for disease ,(1968)
S. G. Wannamethee, O. Papacosta, P. H. Whincup, M. C. Thomas, C. Carson, D. A. Lawlor, S. Ebrahim, N. Sattar, The potential for a two-stage diabetes risk algorithm combining non-laboratory-based scores with subsequent routine non-fasting blood tests: results from prospective studies in older men and women. Diabetic Medicine. ,vol. 28, pp. 23- 30 ,(2011) , 10.1111/J.1464-5491.2010.03171.X
L. A. Sargeant, R. K. Simmons, R. S. Barling, R. Butler, K. M. Williams, A. T. Prevost, A. L. Kinmonth, N. J. Wareham, S. J. Griffin, Who attends a UK diabetes screening programme? Findings from the ADDITION‐Cambridge study Diabetic Medicine. ,vol. 27, pp. 995- 1003 ,(2010) , 10.1111/J.1464-5491.2010.03056.X
A. M.W. Spijkerman, M. F. Yuyun, S. J. Griffin, J. M. Dekker, G. Nijpels, N. J. Wareham, The Performance of a Risk Score as a Screening Test for Undiagnosed Hyperglycemia in Ethnic Minority Groups Data from the 1999 Health Survey for England Diabetes Care. ,vol. 27, pp. 116- 122 ,(2004) , 10.2337/DIACARE.27.1.116
Michael M. Engelgau, Trying to predict the future for people with diabetes: a tough but important task. Annals of Internal Medicine. ,vol. 143, pp. 301- 302 ,(2005) , 10.7326/0003-4819-143-4-200508160-00011
Nadeem Sarwar, Thor Aspelund, Gudny Eiriksdottir, Reeta Gobin, Sreenivasa Rao Kondapally Seshasai, Nita G. Forouhi, Gunnar Sigurdsson, John Danesh, Vilmundur Gudnason, Markers of Dysglycaemia and Risk of Coronary Heart Disease in People without Diabetes: Reykjavik Prospective Study and Systematic Review PLoS Medicine. ,vol. 7, pp. e1000278- ,(2010) , 10.1371/JOURNAL.PMED.1000278